• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2,5-二脱氧-2,5-亚氨基-D-甘露醇作为法布里病的新型药理学伴侣。

2,5-Dideoxy-2,5-imino-d-altritol as a new class of pharmacological chaperone for Fabry disease.

机构信息

Department of Hospital Pharmacy, University of Toyama, Toyama 930-0194, Japan.

出版信息

Bioorg Med Chem. 2010 Jun 1;18(11):3790-4. doi: 10.1016/j.bmc.2010.04.048. Epub 2010 Apr 21.

DOI:10.1016/j.bmc.2010.04.048
PMID:20457528
Abstract

Chromatographic separation of the extract from roots of Adenophora triphylla resulted in the isolation of two pyrrolidines, six piperidines, and two piperidine glycosides. The structures of new iminosugars were elucidated by spectroscopic methods as 2,5-dideoxy-2,5-imino-d-altritol (DIA) (2), beta-1-C-butenyl-1-deoxygalactonojirimycin (8), 2,3-dideoxy-beta-1-C-ethyl-1-deoxygalactonojirimycin (9), and 6-O-beta-d-glucopyranosyl-2,3-dideoxy-beta-1-C-ethyl-1-deoxygalactonojirimycin (10). beta-1-C-Butyl-1-deoxygalactonojirimycin (7) and compound 8 were found to be better inhibitors of alpha-galactosidase than N-butyl-1-deoxygalactonojirimycin. The present work elucidated that DIA was a powerful competitive inhibitor of human lysosome alpha-galactosidase A (alpha-Gal A) with a K(i) value of 0.5muM. Furthermore, DIA improved the thermostability of alpha-Gal A in vitro and increased intracellular alpha-Gal A activity by 9.6-fold in Fabry R301Q lymphoblasts after incubation for 3days. These experimental results suggested that DIA would act as a specific pharmacological chaperone to promote the smooth escape from the endoplasmic reticulum (ER) quality control system and to accelerate transport and maturation of the mutant enzyme.

摘要

从三叶沙参根的提取物中通过色谱分离得到了两个吡咯烷、六个哌啶和两个哌啶糖苷。通过光谱方法阐明了新的亚氨基糖的结构为 2,5-二脱氧-2,5-亚氨基-d-阿糖醇(DIA)(2)、β-1-C-丁烯基-1-脱氧半乳糖基基二氢吡咯烷(8)、2,3-二脱氧-β-1-C-乙基-1-脱氧半乳糖基二氢吡咯烷(9)和 6-O-β-d-吡喃葡萄糖基-2,3-二脱氧-β-1-C-乙基-1-脱氧半乳糖基二氢吡咯烷(10)。发现β-1-C-丁基-1-脱氧半乳糖基二氢吡咯烷(7)和化合物 8 是比 N-丁基-1-脱氧半乳糖基二氢吡咯烷更好的α-半乳糖苷酶抑制剂。本工作阐明了 DIA 是一种有效的人溶酶体α-半乳糖苷酶 A(α-Gal A)竞争性抑制剂,K(i)值为 0.5μM。此外,DIA 提高了α-Gal A 在体外的热稳定性,并在孵育 3 天后使 Fabry R301Q 淋巴母细胞内的α-Gal A 活性增加了 9.6 倍。这些实验结果表明,DIA 将作为一种特异性的药理学伴侣,促进突变酶从内质网(ER)质量控制系统中顺利逃逸,并加速其转运和成熟。

相似文献

1
2,5-Dideoxy-2,5-imino-d-altritol as a new class of pharmacological chaperone for Fabry disease.2,5-二脱氧-2,5-亚氨基-D-甘露醇作为法布里病的新型药理学伴侣。
Bioorg Med Chem. 2010 Jun 1;18(11):3790-4. doi: 10.1016/j.bmc.2010.04.048. Epub 2010 Apr 21.
2
Pharmacological chaperone therapy by active-site-specific chaperones in Fabry disease: in vitro and preclinical studies.法布里病中活性位点特异性伴侣分子的药理伴侣疗法:体外和临床前研究
Int J Clin Pharmacol Ther. 2009;47 Suppl 1:S111-7.
3
Active-site-specific chaperone therapy for Fabry disease. Yin and Yang of enzyme inhibitors.法布里病的活性位点特异性伴侣蛋白疗法。酶抑制剂的阴阳之道。
FEBS J. 2007 Oct;274(19):4962-71. doi: 10.1111/j.1742-4658.2007.06041.x.
4
In vitro inhibition and intracellular enhancement of lysosomal alpha-galactosidase A activity in Fabry lymphoblasts by 1-deoxygalactonojirimycin and its derivatives.1-脱氧半乳糖野尻霉素及其衍生物对法布里病淋巴母细胞中溶酶体α-半乳糖苷酶A活性的体外抑制和细胞内增强作用
Eur J Biochem. 2000 Jul;267(13):4179-86. doi: 10.1046/j.1432-1327.2000.01457.x.
5
Tuning glycosidase inhibition through aglycone interactions: pharmacological chaperones for Fabry disease and GM1 gangliosidosis.通过糖苷酶抑制剂的非糖部分相互作用进行调节:法布雷病和神经节苷脂贮积症的药理学伴侣分子。
Chem Commun (Camb). 2012 Jul 4;48(52):6514-6. doi: 10.1039/c2cc32065g. Epub 2012 May 23.
6
Pharmacological chaperone corrects lysosomal storage in Fabry disease caused by trafficking-incompetent variants.药理学伴侣可纠正由转运功能缺陷变体引起的法布里病中的溶酶体贮积。
Am J Physiol Cell Physiol. 2006 Apr;290(4):C1076-82. doi: 10.1152/ajpcell.00426.2005.
7
New polyhydroxylated pyrrolidine, piperidine, and pyrrolizidine alkaloids from Scilla sibirica.来自西伯利亚绵枣儿的新型多羟基化吡咯烷、哌啶和吡咯里西啶生物碱。
J Nat Prod. 2002 Dec;65(12):1875-81. doi: 10.1021/np020296h.
8
Molecular interaction of imino sugars with human alpha-galactosidase: Insight into the mechanism of complex formation and pharmacological chaperone action in Fabry disease.亚氨基糖与人α-半乳糖苷酶的分子相互作用:对法布里病中复合物形成机制及药理伴侣作用的深入了解。
Mol Genet Metab. 2009 Apr;96(4):233-8. doi: 10.1016/j.ymgme.2008.12.017. Epub 2009 Jan 31.
9
Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor.一种酶抑制剂加速法布里成淋巴细胞中溶酶体α-半乳糖苷酶A的转运与成熟
Nat Med. 1999 Jan;5(1):112-5. doi: 10.1038/4801.
10
Polyhydroxylated pyrrolidine and piperidine alkaloids from Adenophora triphylla var. japonica (Campanulaceae).轮叶沙参(桔梗科)中的多羟基化吡咯烷和哌啶生物碱。
Phytochemistry. 2000 Feb;53(3):379-82. doi: 10.1016/s0031-9422(99)00555-5.

引用本文的文献

1
Development of iminosugar-based glycosidase inhibitors as drug candidates for SARS-CoV-2 virus via molecular modelling and in vitro studies.基于脒基糖的糖苷酶抑制剂的开发:通过分子建模和体外研究作为 SARS-CoV-2 病毒的药物候选物。
J Enzyme Inhib Med Chem. 2024 Dec;39(1):2289007. doi: 10.1080/14756366.2023.2289007. Epub 2023 Dec 12.
2
New α-galactosidase-inhibiting aminohydroxycyclopentanes.新型α-半乳糖苷酶抑制性氨基羟基环戊烷。
RSC Adv. 2021 Apr 29;11(26):15943-15951. doi: 10.1039/d1ra02507d. eCollection 2021 Apr 26.
3
New Approaches to Tay-Sachs Disease Therapy.
泰-萨克斯病治疗的新方法。
Front Physiol. 2018 Nov 20;9:1663. doi: 10.3389/fphys.2018.01663. eCollection 2018.
4
Tuning protein folding in lysosomal storage diseases: the chemistry behind pharmacological chaperones.调节溶酶体贮积症中的蛋白质折叠:药理伴侣背后的化学原理。
Chem Sci. 2018 Jan 10;9(7):1740-1752. doi: 10.1039/c7sc04712f. eCollection 2018 Feb 21.
5
Glycosphingolipid storage in Fabry mice extends beyond globotriaosylceramide and is affected by ABCB1 depletion.法布里病小鼠中的糖鞘脂储存超出了三己糖神经酰胺的范围,并受到ABCB1缺失的影响。
Future Sci OA. 2016 Oct 13;2(4):FSO147. doi: 10.4155/fsoa-2016-0027. eCollection 2016 Dec.
6
The Large Phenotypic Spectrum of Fabry Disease Requires Graduated Diagnosis and Personalized Therapy: A Meta-Analysis Can Help to Differentiate Missense Mutations.法布里病的广泛表型谱需要分级诊断和个性化治疗:一项荟萃分析有助于区分错义突变。
Int J Mol Sci. 2016 Dec 1;17(12):2010. doi: 10.3390/ijms17122010.
7
Using pharmacological chaperones to restore proteostasis.使用药理学伴侣分子来恢复蛋白质稳态。
Pharmacol Res. 2014 May;83:3-9. doi: 10.1016/j.phrs.2014.04.002. Epub 2014 Apr 18.
8
Identification and characterization of pharmacological chaperones to correct enzyme deficiencies in lysosomal storage disorders.鉴定和表征用于纠正溶酶体贮积症中酶缺陷的药理学伴侣分子。
Assay Drug Dev Technol. 2011 Jun;9(3):213-35. doi: 10.1089/adt.2011.0370.